UNSPSC 85872406: Fluoroscopy of other upper arteries using high osmolar contrast

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of other upper arteries using high osmolar contrast. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code B31N0ZZ

UNSPSC 85872406 Fluoroscopy of other upper arteries using high osmolar contrast is a Commodity code that shows minimal alignment with the recent state and local opportunities posted under it. The three most recent solicitations span diagnostic imaging systems infrastructure (picture archiving and communication systems), portable ultrasound equipment and warranties, and phlebotomy on-call services — none of which constitute fluoroscopy procedures or contrast-agent procurement as the code nominally describes. The mismatch suggests that this code either receives sparse, misdirected tagging in state and local procurement systems or that the opportunities indexed under it do not reflect the actual scope of work the code is designed to cover. State and local governments appear to procure fluoroscopy and contrast services through channels not well represented in the recent-opportunities block, or the code receives minimal activity overall.

The geographic spread across the recent opportunities spans California (San Mateo County), Florida (Collier County), and New Mexico (Albuquerque), with issuing bodies including a county health system, a county procurement division, and a municipal police department. No repeat buyers or concentrated geographic cluster emerges from the three opportunities. The San Mateo Medical Center RFP for Diagnostic Imaging PACS (due August 7, 2026) and the Collier County Notice of Intent to Single Source EchoNous ultrasound equipment (posted April 1, 2026) represent health-system infrastructure procurement rather than clinical fluoroscopy services. The Albuquerque Police Department RFB for blood draw services (due February 25, 2026) falls outside diagnostic imaging entirely. This code warrants monitoring for activity clarification rather than immediate pursuit, pending evidence that state and local opportunities under it align with fluoroscopy and contrast procurement.